# Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease

> **NCT05305833** · PHASE1,PHASE2 · UNKNOWN · sponsor: **TC Erciyes University** · enrollment: 20 (estimated)

## Conditions studied

- Temporomandibular Joint Disorders
- Temporomandibular Disorder
- Temporomandibular Joint Osteoarthritis
- Temporomandibular Joint Pain
- Temporomandibular Joint Effusion

## Interventions

- **BIOLOGICAL:** Stem Cells

## Key facts

- **NCT ID:** NCT05305833
- **Lead sponsor:** TC Erciyes University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305833, "Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05305833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*